143 related articles for article (PubMed ID: 36175877)
1. Identification of TLN1 as a prognostic biomarker to effect cell proliferation and differentiation in acute myeloid leukemia.
Cui D; Cui X; Xu X; Zhang W; Yu Y; Gao Y; Mei C; Zheng W
BMC Cancer; 2022 Sep; 22(1):1027. PubMed ID: 36175877
[TBL] [Abstract][Full Text] [Related]
2. miR-9 functions as a tumor suppressor in ovarian serous carcinoma by targeting TLN1.
Tang H; Yao L; Tao X; Yu Y; Chen M; Zhang R; Xu C
Int J Mol Med; 2013 Aug; 32(2):381-8. PubMed ID: 23722670
[TBL] [Abstract][Full Text] [Related]
3. Talin-dependent integrin activation is required for endothelial proliferation and postnatal angiogenesis.
Pulous FE; Carnevale JC; Al-Yafeai Z; Pearson BH; Hamilton JAG; Henry CJ; Orr AW; Petrich BG
Angiogenesis; 2021 Feb; 24(1):177-190. PubMed ID: 33113074
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of AZIN2-sv induces neovascularization and improves prognosis after myocardial infarction by blocking ubiquitin-dependent talin1 degradation and activating the Akt pathway.
Li X; Sun Y; Huang S; Chen Y; Chen X; Li M; Si X; He X; Zheng H; Zhong L; Yang Y; Liao W; Liao Y; Chen G; Bin J
EBioMedicine; 2019 Jan; 39():69-82. PubMed ID: 30545799
[TBL] [Abstract][Full Text] [Related]
5. Talin-1 overexpression defines high risk for aggressive oral squamous cell carcinoma and promotes cancer metastasis.
Lai MT; Hua CH; Tsai MH; Wan L; Lin YJ; Chen CM; Chiu IW; Chan C; Tsai FJ; Jinn-Chyuan Sheu J
J Pathol; 2011 Jul; 224(3):367-76. PubMed ID: 21547905
[TBL] [Abstract][Full Text] [Related]
6. Talin1 has unique expression versus talin 2 in the heart and modifies the hypertrophic response to pressure overload.
Manso AM; Li R; Monkley SJ; Cruz NM; Ong S; Lao DH; Koshman YE; Gu Y; Peterson KL; Chen J; Abel ED; Samarel AM; Critchley DR; Ross RS
J Biol Chem; 2013 Feb; 288(6):4252-64. PubMed ID: 23266827
[TBL] [Abstract][Full Text] [Related]
7. FLT3 signals via the adapter protein Grb10 and overexpression of Grb10 leads to aberrant cell proliferation in acute myeloid leukemia.
Kazi JU; Rönnstrand L
Mol Oncol; 2013 Jun; 7(3):402-18. PubMed ID: 23246379
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of long noncoding RNA HOXA-AS2 predicts an adverse prognosis and promotes tumorigenesis via SOX4/PI3K/AKT pathway in acute myeloid leukemia.
Qu Y; Wang Y; Wang P; Lin N; Yan X; Li Y
Cell Biol Int; 2020 Aug; 44(8):1745-1759. PubMed ID: 32369230
[TBL] [Abstract][Full Text] [Related]
9. Identification of the key genes and microRNAs in adult acute myeloid leukemia with FLT3 mutation by bioinformatics analysis.
Chen S; Chen Y; Zhu Z; Tan H; Lu J; Qin P; Xu L
Int J Med Sci; 2020; 17(9):1269-1280. PubMed ID: 32547322
[No Abstract] [Full Text] [Related]
10. [Prognostic implications and functional enrichment analysis of LTB4R in patients with acute myeloid leukemia].
Zhang X; Zhang X; Liu P; Liu K; Li W; Chen Q; Ma W
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Mar; 42(3):309-320. PubMed ID: 35426793
[TBL] [Abstract][Full Text] [Related]
11. Bioinformatics Analysis Identifies Key Genes and Pathways in Acute Myeloid Leukemia Associated with DNMT3A Mutation.
Chen S; Chen Y; Lu J; Yuan D; He L; Tan H; Xu L
Biomed Res Int; 2020; 2020():9321630. PubMed ID: 33299888
[TBL] [Abstract][Full Text] [Related]
12. ZEB1 serves as an oncogene in acute myeloid leukaemia via regulating the PTEN/PI3K/AKT signalling pathway by combining with P53.
Li L; Feng Y; Hu S; Du Y; Xu X; Zhang M; Peng X; Chen F
J Cell Mol Med; 2021 Jun; 25(11):5295-5304. PubMed ID: 33960640
[TBL] [Abstract][Full Text] [Related]
13. Circ_0009910 sponges miR-491-5p to promote acute myeloid leukemia progression through modulating B4GALT5 expression and PI3K/AKT signaling pathway.
Wu Y; Zhao B; Chen X; Geng X; Zhang Z
Int J Lab Hematol; 2022 Apr; 44(2):320-332. PubMed ID: 34709725
[TBL] [Abstract][Full Text] [Related]
14. MiR-592 functions as a tumor suppressor in acute myeloid leukemia by targeting ROCK1 and predicts patients' prognosis.
Xu Y; Li K; Wang SB; Yang SG
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1610-1619. PubMed ID: 30840284
[TBL] [Abstract][Full Text] [Related]
15. HCK is a Potential Prognostic Biomarker that Correlates with Immune Cell Infiltration in Acute Myeloid Leukemia.
Cheng F; Li Q; Wang J; Wang L; Li W; Zeng F
Dis Markers; 2022; 2022():3199589. PubMed ID: 35280440
[TBL] [Abstract][Full Text] [Related]
16. Tumor suppressor miR-139-5p targets Tspan3 and regulates the progression of acute myeloid leukemia through the PI3K/Akt pathway.
Zhang R; Tang P; Wang F; Xing Y; Jiang Z; Chen S; Meng X; Liu L; Cao W; Zhao H; Ma P; Chen Y; An C; Sun L
J Cell Biochem; 2019 Mar; 120(3):4423-4432. PubMed ID: 30367526
[TBL] [Abstract][Full Text] [Related]
17. Bioinformatics-based identification of SPNS3 (Spinster homolog 3) as a prognostic biomarker of apoptosis resistance in acute myeloid leukemia.
Hong Y; Tian X; Wang M; Chen C; Sun A
Bioengineered; 2021 Dec; 12(1):7837-7848. PubMed ID: 34608834
[TBL] [Abstract][Full Text] [Related]
18. Single-cell mass cytometry reveals intracellular survival/proliferative signaling in FLT3-ITD-mutated AML stem/progenitor cells.
Han L; Qiu P; Zeng Z; Jorgensen JL; Mak DH; Burks JK; Schober W; McQueen TJ; Cortes J; Tanner SD; Roboz GJ; Kantarjian HM; Kornblau SM; Guzman ML; Andreeff M; Konopleva M
Cytometry A; 2015 Apr; 87(4):346-56. PubMed ID: 25598437
[TBL] [Abstract][Full Text] [Related]
19. CXCL8 derived from mesenchymal stromal cells supports survival and proliferation of acute myeloid leukemia cells through the PI3K/AKT pathway.
Cheng J; Li Y; Liu S; Jiang Y; Ma J; Wan L; Li Q; Pang T
FASEB J; 2019 Apr; 33(4):4755-4764. PubMed ID: 30592634
[TBL] [Abstract][Full Text] [Related]
20.
Zhou JD; Li XX; Zhang TJ; Xu ZJ; Zhang ZH; Gu Y; Wen XM; Zhang W; Ji RB; Deng ZQ; Lin J; Qian J
Aging (Albany NY); 2019 May; 11(10):3376-3391. PubMed ID: 31147526
[No Abstract] [Full Text] [Related]
[Next] [New Search]
